Overwhelming Response To Sarveshwar Foods Limited Rights Issue Of 24,99,10,469 Fully Paid-Up Equity Shares Aggregating To Rs. 149.95 Crores

Srinagar (Jammu & Kashmir) [India], September 17: Sarveshwar Foods Limited today announced that it has achieved successful closure of Rights Issue of 24,99,10,469 (Twenty-Four Crore Ninety-Nine Lakh Ten Thousand Four Hundred Sixty- Nine) Fully paid-up Equity Shares aggregating to ₹ 149.95 Cr. having issue price of ₹ 6/- per Equity Share (including a share premium of ₹ 5 per share) (the “issue price”) on a rights basis to the eligible equity shareholders of our Company closed successfully on September 16, 2025.

Amount Payable per Rights Equity Share

i.e. Issue Price

Face value () Premium () Total
On Application 1.00 5.00 6.00

The Rights issue was oversubscribed by 1.35 times.

Sarveshwar Foods Limited, is engaged in the business of manufacturing, trading, processing, and marketing of branded and un-branded basmati and non-basmati rice in the domestic and international markets, announced today the successful closure of the issue of 24,99,10,469 (Twenty-Four Crore Ninety-Nine Lakh Ten Thousand Four Hundred & Sixty-Nine) Fully paid−up Equity Shares (including a share premium of ₹ 5 per share) (the “issue price”) on rights basis to the eligible equity shareholders (the “Rights Issue”) which was launched on September 02, 2025.

The issue resulted into subscription of 33,85,67,058 shares resulting into oversubscription by 1.35 times. The issue period was from September 02, 2025, to September 16, 2025. The issue size was 24,99,10,469 (Twenty- Four Crore Ninety-Nine Lakh Ten Thousand Four Hundred Sixty-Nine) Fully paid-up Equity Shares aggregating to ₹ 149.95 Cr. having issue price of ₹ 6/- per Equity Share (including a share premium of ₹ 5 per share) (the “issue price”) on a rights basis to its eligible equity shareholders in the ratio of 12 (Twelve) Rights Equity Share for every 47 (Fourty-Seven) fully paid-up Equity Shares held as on record date i.e. August 22, 2025. The payment schedule for this issue is fully paid up, with 100% of the amount i.e. ₹6 per share, payable at the time of application.

The funds raised via rights issue will be used in the manner described in the Letter of Offer dated August 21, 2025., i.e.

  1. To augment the existing and incremental working capital requirement of our Company.
  2. General Corporate Purpose

The allotment and listing formalities of the new shares on the BSE and NSE are expected to be completed on or about Wednesday, September 17, 2025 and Friday, September 19, 2025 respectively.

Commenting on the success of the Rights Issue, Shri Mr. Rohit Gupta, Chairman of Sarveshwar Foods Limited, said, “I express my sincere thanks to our dear and esteemed shareholders for participating in this Rights Issue and making it a new and proud landmark in the history of India’s capital market.

Our shareholders have always been our biggest source of strength. Our decades-old relationship based on trust has consistently spurred us to achieve more. We are delighted and humbled by their extraordinary show of confidence in the future of Sarveshwar.

Intermediaries for this rights issue:

  • Bigshare Services Private Limited – Registrar to the Issue
  • KRA & Co, Chartered Accountants – Statutory Auditor to the Company,
  • Kotak Mahindra Bank Limited – Banker to the Issue.

If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.

Business

Fischer Medical Subsidiary, Time Medical India, Collaborates with Dr. Cherian to Pioneer Next-Generation AI-Enabled MRI System

Mumbai (Maharashtra) [India], November 4: Fischer Medical Ventures Limited (FISCHER | 524743 | INE771F01041), Time Medical International Ventures (I) P LTD, the wholly owned subsidiary of Fischer Medical Ventures Limited, today announced a strategic collaboration with globally acclaimed neurosurgeon, educator, and innovator Dr Iype Cherian. The collaboration’s sole purpose is the development of DRIS–iMRI Medharanya, a […]

Read More
Agartala Business Dr. Saikat Kar innovation Neurotech Startup Science

From Agartala to Global Innovation: How Tripura’s First Neurotech Startup is Bridging Brain Science with Grassroots Impact

Agartala (Tripura) [India], November 4: In a region celebrated for tea gardens and handicrafts rather than technological ambition, a quiet revolution is unfolding. Codonmind Nexus Private Limited, the Northeast’s pioneering neurotechnology startup, is developing brain-computer interface devices and advanced neurological research tools positioned to compete with national players in a market projected to reach USD […]

Read More
Business Harsheep Hortico Limited

Harshdeep Hortico Reports Strong H1 FY26 with Net Profit of INR 5.7 crore

Mumbai (Maharashtra) [India], November 4: Harsheep Hortico Limited (BSE: HARSHDEEP), specializing in the manufacture and export of pots, planters, garden accessories, and outdoor furniture; announced its Unaudited financials for H1 FY26. Key H1 FY25 Financial Highlights Key Financial Highlights (Consolidated) – H1 FY2025-26 Revenue for H1 FY2025–26 was ₹37.84 crore, compared to ₹24.09 crore in […]

Read More